Refine by
Immunai Biopharma To Participate In Panel Discussion On Investment Opportunities In China Hosted By Duane Morris And The Chinese Biopharmaceutical Software
1 software items found
by:Immunai based inNew York, NEW YORK (USA)
Immunai’s end-to-end single-cell platform enables high resolution profiling of the immune system at industrial scale, generating biological insights that accelerate R&D and power novel ...